Tom Gayner Markel Group
Tom Gayner is the CEO of Markel Group and long-time steward of its public equity portfolio. Often compared to a smaller-scale Berkshire-style model, Markel combines insurance operations with a carefully selected book of common stocks. Gayner is known for a patient, owner-oriented philosophy and for writing clearly about compounding, culture, and long-term business ownership.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$25.3M |
| 2 |
Unilever
UL
|
+$8.57M |
| 3 |
SLB Ltd
SLB
|
+$7.18M |
| 4 |
LBRDK
Liberty Broadband Class C
LBRDK
|
+$6.35M |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$6.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$23.9M |
| 2 |
Brown & Brown
BRO
|
+$6.42M |
| 3 |
Automatic Data Processing
ADP
|
+$5.98M |
| 4 |
Liberty Media Series C
FWONK
|
+$5.79M |
| 5 |
Coca-Cola
KO
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.08% |
| 2 | Consumer Discretionary | 16.02% |
| 3 | Consumer Staples | 12.53% |
| 4 | Industrials | 11.33% |
| 5 | Healthcare | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OAK
76
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $7.93M | 0.2% |
153,000
+118,000
| +337% | +$5.7M |
|
|
PDCO
77
DELISTED
Patterson Companies, Inc.
PDCO
| $7.46M | 0.19% |
155,000
| – | – |
|
|
CDK
78
DELISTED
CDK Global, Inc.
CDK
| $7.21M | 0.18% |
+176,897
| New | +$6.27M |
|
79
Apollo Global Management
APO
$78.6B
| $7.19M | 0.18% |
305,000
+30,000
| +11% | +$692K |
|
80
Paychex
PAYX
$44.9B
| $6.92M | 0.17% |
150,000
| – | – |
|
81
Upbound Group
UPBD
$1.12B
| $6.9M | 0.17% |
190,000
+16,000
| +9% | +$515K |
|
|
LBRDK
82
DELISTED
Liberty Broadband Class C
LBRDK
| $6.43M | 0.16% |
+129,000
| New | +$6.35M |
|
83
Expeditors International
EXPD
$24.3B
| $6.11M | 0.15% |
137,000
| – | – |
|
84
RTX Corp
RTX
$282B
| $6.09M | 0.15% |
84,217
| – | – |
|
85
Costco
COST
$429B
| $5.53M | 0.14% |
39,000
| – | – |
|
|
86
Brown & Brown
BRO
$24.9B
| $5.45M | 0.14% |
331,256
-400,000
| -55% | -$6.42M |
|
87
CME Group
CME
$100B
| $4.96M | 0.13% |
56,000
+11,000
| +24% | +$932K |
|
88
MSCI
MSCI
$41.4B
| $4.79M | 0.12% |
101,000
+15,000
| +17% | +$702K |
|
89
Graham Holdings Company
GHC
$4.98B
| $4.49M | 0.11% |
8,606
| – | – |
|
|
LBRDA
90
DELISTED
Liberty Broadband Class A
LBRDA
| $4.02M | 0.1% |
+80,250
| New | +$3.97M |
|
91
Rollins
ROL
$18.1B
| $3.38M | 0.09% |
344,250
+50,625
| +17% | +$473K |
|
92
Core Laboratories
CLB
$553M
| $3.01M | 0.08% |
25,000
+15,000
| +150% | +$1.97M |
|
|
CRR
93
DELISTED
Carbo Ceramics Inc.
CRR
| $2.44M | 0.06% |
+61,000
| New | +$2.85M |
|
94
DNOW Inc
DNOW
$2.81B
| $2.41M | 0.06% |
93,500
| – | – |
|
95
Ross Stores
ROST
$75.8B
| $2.17M | 0.05% |
46,000
| – | – |
|
|
Y
96
DELISTED
Alleghany Corp
Y
| $2.01M | 0.05% |
4,328
| – | – |
|
97
RB Global
RBA
$15.7B
| $1.85M | 0.05% |
69,000
+19,000
| +38% | +$471K |
|
|
OMCC
98
DELISTED
Old Market Capital Corp
OMCC
| $670K | 0.02% |
45,000
+35,000
| +350% | +$433K |
|
99
Culp Inc
CULP
$44.4M
| $655K | 0.02% |
30,227
| – | – |
|
100
Cisco
CSCO
$437B
| $640K | 0.02% |
23,000
| – | – |
|
Similar funds
Tom Gayner's Q4 2014 Portfolio in Review
As of Q4 2014, Tom Gayner held 112 positions worth $3.97B, up 12% from $3.55B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Tom Gayner's Q4 2014 filing shows 9 new, 42 increased, 4 reduced and 6 closed positions. Its largest new stake was Liberty Broadband Class C: 129,000 shares worth $6.43M. The largest sale was Teva Pharmaceuticals, an estimated $23.9M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Tom Gayner's largest Q4 2014 buy was Liberty Broadband Class C: 129,000 shares worth $6.43M.
- Tom Gayner added most to Deere & Co in Q4 2014, an estimated $25.3M increase.
- Tom Gayner's biggest Q4 2014 reduction was Brown & Brown, cutting an estimated $6.42M.
- Tom Gayner fully exited Teva Pharmaceuticals in Q4 2014, selling an estimated $23.9M.
- Tom Gayner's ten largest holdings make up 44% of its $3.97B portfolio in Q4 2014.
- Tom Gayner opened 9 new positions and closed 6 in Q4 2014.
- Tom Gayner's portfolio value rose 12% quarter-over-quarter to $3.97B.
Based on Markel Group's 13F filing for Q4 2014, filed 9 Feb 2015.